Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Down 16.7% in November

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 500 shares, a decrease of 16.7% from the November 15th total of 600 shares. Based on an average daily trading volume, of 600 shares, the short-interest ratio is presently 0.8 days.

Mosaic ImmunoEngineering Stock Performance

Shares of CPMV stock remained flat at $1.00 during mid-day trading on Friday. The stock had a trading volume of 26 shares, compared to its average volume of 314. Mosaic ImmunoEngineering has a 52-week low of $0.10 and a 52-week high of $1.13. The company has a 50-day moving average of $0.92 and a 200-day moving average of $0.81. The firm has a market capitalization of $7.24 million, a PE ratio of -6.67 and a beta of 0.15.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.